ASTELLAS PHARMA US, INC. for ASTELLAS PHARMA US, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to the pharmaceutical sales fee and clarification of the orphan drug exemption (no specific bills)
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RYAN AMBROSE New | House Committee on Energy & Commerce, Clerk |
| MARY LACEY REUTHER | — |
| MICHAEL RUGGIERO | — |
Health Issues HCR
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152) Issues related to the development of new antibiotics (the Generating Antibiotic Incentives Now Act (H.R. 2182/S.1734)) Issues related to reauthorization of the Prescription Drug User Fee Act (no specific bills) Issues related to drug shortages (Preserving Access to Life-Saving Medications Act of 2011 (H.R.2245) and Preserving Access to Life-Saving Medications Act (S.296) )
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RYAN AMBROSE New | House Committee on Energy & Commerce, Clerk |
| MARY LACEY REUTHER | — |
| MICHAEL RUGGIERO | — |
Medicare/Medicaid MMM
Issues related to the implementation of health care reform (P.L. 111-148, P.L. 111-152). Issues related to the debt ceiling negotiations and Medicare Part D rebates (no specific bills).
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RYAN AMBROSE New | House Committee on Energy & Commerce, Clerk |
| MARY LACEY REUTHER | — |
| MICHAEL RUGGIERO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.